Strategies for Managing Neurotoxic AEs With Lorlatinib
Key opinion leaders discuss strategies for managing neurotoxicity with lorlatinib and other ALK inhibitors, including monitoring adverse events and balancing symptom management with treatment efficacy.
Video content above is prompted by the following:
- Can you discuss your strategies for managing neurotoxicity?
- How are you monitoring these AEs?
- How do you balance symptom management with maintaining treatment efficacy?
Recent Videos
Related Content
